Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |